Gp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation
Claudia A. Nold‐Petry(Hudson Institute of Medical Research), Charles A. Dinarello(University of Colorado Anschutz Medical Campus)
Cited by 7
Related Papers
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
|Blood|2008|777
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation
|Critical Care Medicine|2000|372
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
|Nature Immunology|2016|365